1. Short title This Act may be cited as the United States-Abraham Accords Cooperation and Security Act of 2024 . 2. Establishment of Abraham Accords Bureau within Food and Drug Administration (a) In general Chapter X of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 391 et seq. ) is amended by adding at the end the following: 1015. Abraham Accords Bureau (a) In general The Secretary, acting through the Commissioner of Food and Drugs, shall establish within the Food and Drug Administration a bureau, to be known as the Abraham Accords Bureau, to be headed by a director. (b) Offices Not later than one year after the date of enactment of this section, the Secretary shall— (1) in consultation with the governments of Abraham Accords countries— (A) select the locations of one or more offices of the Abraham Accords Bureau in one or more Abraham Accords countries; and (B) establish each such office; and (2) assign to each such office such personnel of the Food and Drug Administration as the Secretary determines necessary to carry out the functions of the office. (c) Duties The Secretary, acting through the Director of the Abraham Accords Bureau, shall— (1) not later than 90 days after all offices of the Abraham Accords Bureau are established— (A) develop a list of essential medical, biomedical, and life sciences products, the key raw pharmaceutical ingredients of such products, and the active pharmaceutical ingredients of such products, that are primarily manufactured in a covered country; (B) develop a list of medical, biomedical, and life sciences facilities and entities in Abraham Accord countries that can engage with offices of the Abraham Accords Bureau to bolster the United States’ health care and medical supply needs; and (C) submit such lists to the Congress; (2) not less than every 3 years thereafter, update the lists under paragraph (1) and submit the updated lists to the Congress